ARTICLE | Clinical News
Cangrelor: Phase III started
November 8, 2010 8:00 AM UTC
The Medicines Co. began the double-blind, U.S. Phase III CHAMPION PHOENIX trial to compare Cangrelor vs. Plavix clopidogrel in 10,900 patients requiring PCI. The Medicines Co. has exclusive, worldwi...